Literature DB >> 19713544

Turning point in myocarditis.

Madeleine W Cunningham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19713544      PMCID： PMC2735756          DOI： 10.1161/CIRCRESAHA.109.205195

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  45 in total

1.  Myocarditis: the Dallas criteria.

Authors:  H T Aretz
Journal:  Hum Pathol       Date:  1987-06       Impact factor: 3.466

Review 2.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

Review 3.  Classification and natural history of primary myocardial disease.

Authors:  W H Abelmann
Journal:  Prog Cardiovasc Dis       Date:  1984 Sep-Oct       Impact factor: 8.194

4.  Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy.

Authors:  B Maisch; P Deeg; G Liebau; K Kochsiek
Journal:  Am J Cardiol       Date:  1983-11-01       Impact factor: 2.778

5.  Rheumatic fever: the interplay between host, genetics, and microbe. Lewis A. Conner memorial lecture.

Authors:  J B Zabriskie
Journal:  Circulation       Date:  1985-06       Impact factor: 29.690

6.  Coxsackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains.

Authors:  A Herskowitz; L J Wolfgram; N R Rose; K W Beisel
Journal:  J Am Coll Cardiol       Date:  1987-06       Impact factor: 24.094

7.  Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice.

Authors:  L J Wolfgram; K W Beisel; A Herskowitz; N R Rose
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

8.  Cardiac myosin induces myocarditis in genetically predisposed mice.

Authors:  N Neu; N R Rose; K W Beisel; A Herskowitz; G Gurri-Glass; S W Craig
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

9.  Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes.

Authors:  S A Huber; L P Job; J F Woodruff
Journal:  Am J Pathol       Date:  1980-03       Impact factor: 4.307

10.  Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy.

Authors:  N E Bowles; P J Richardson; E G Olsen; L C Archard
Journal:  Lancet       Date:  1986-05-17       Impact factor: 79.321
View more
  3 in total

Review 1.  Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Jay Reddy
Journal:  Int J Cardiol       Date:  2014-10-18       Impact factor: 4.164

Review 2.  Advances in monoclonal antibody application in myocarditis.

Authors:  Li-na Han; Shuang He; Yu-tang Wang; Li-ming Yang; Si-yu Liu; Ting Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

3.  Therapeutic administration of the chemokine CXCL1/KC abrogates autoimmune inflammatory heart disease.

Authors:  Kurt Bachmaier; Sophie Toya; Asrar B Malik
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.